Compounds > fluconazole

fluconazole and naphthoquinones

fluconazole has been researched along with naphthoquinones in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (37.50)18.2507
2000's2 (25.00)29.6817
2010's2 (25.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Collins, JM; Jamis-Dow, C; Klecker, RW; Trapnell, CB1
Gibbs, D; Goyal, A; Kumar, P; Makharia, M; Murray, H; Rogers, M; Sundar, S1
Kumar, M; Maurya, HK; Shukla, PK; Tandon, VK; Tripathi, A; Yadav, DB1
Aperis, G; Ausubel, FM; Breger, J; Fuchs, BB; Moy, TI; Mylonakis, E1
Campos, RS; Carvalho, TS; Cavalcanti, BC; da Silva Júnior, EN; da Silva, CR; de Moraes, MO; Diogo, EB; Gaspar, DM; Grangeiro, TB; Júnior, HV; Lobo, MD; Magalhães, HI; Neta, MA; Neto, JB; Rodrigues, FA; Siebra, JT; Silva, RA1
Campos, RS; Cavalcanti, BC; da Silva Júnior, EN; da Silva, AR; da Silva, CR; de Andrade Neto, JB; de Azevedo Moreira, R; de Moraes, MO; do Nascimento, FBSA; Grangeiro, TB; Josino, MAA; Júnior, HVN; Lobo, MDP; Magalhães, HIF; Moreira, ACOM; Moreno, FBMB; Rocha, DD; Sampaio, LS1
Cardoso, KM; de Moraes, DC; do Carmo Freire Ribeiro Pinto, M; Domingos, LTS; Ferreira-Pereira, A; Monteiro, RQ1

Trials

1 trial(s) available for fluconazole and naphthoquinones

ArticleYear
Atovaquone alone or with fluconazole as oral therapy for Indian kala-azar.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 27, Issue:1

    Topics: Adolescent; Adult; Animals; Antifungal Agents; Antiprotozoal Agents; Atovaquone; Child; Child, Preschool; Drug Therapy, Combination; Female; Fluconazole; Humans; Leishmaniasis, Visceral; Male; Middle Aged; Naphthoquinones; Pilot Projects

1998

Other Studies

7 other study(ies) available for fluconazole and naphthoquinones

ArticleYear
Drugs for AIDS and associated infections.
    The Medical letter on drugs and therapeutics, 1995, Oct-13, Volume: 37, Issue:959

    Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine

1995
Glucuronidation of 3'-azido-3'-deoxythymidine (zidovudine) by human liver microsomes: relevance to clinical pharmacokinetic interactions with atovaquone, fluconazole, methadone, and valproic acid.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:7

    Topics: Anti-HIV Agents; Anticonvulsants; Antifungal Agents; Atovaquone; Drug Interactions; Fluconazole; Glucuronates; Humans; In Vitro Techniques; Methadone; Microsomes, Liver; Naphthoquinones; Narcotics; Valproic Acid; Zidovudine

1998
Naphtho[2,3-b][1,4]-thiazine-5,10-diones and 3-substituted-1,4-dioxo-1,4-dihydronaphthalen-2-yl-thioalkanoate derivatives: synthesis and biological evaluation as potential antibacterial and antifungal agents.
    Bioorganic & medicinal chemistry letters, 2006, Nov-15, Volume: 16, Issue:22

    Topics: Anti-Bacterial Agents; Antifungal Agents; Cryptococcus neoformans; Drug Design; Fluconazole; Gentamicins; Naphthoquinones; Sporothrix; Staphylococcus aureus; Structure-Activity Relationship; Thiazines; Trichophyton

2006
Antifungal chemical compounds identified using a C. elegans pathogenicity assay.
    PLoS pathogens, 2007, Volume: 3, Issue:2

    Topics: Animals; Antifungal Agents; Biofilms; Caenorhabditis elegans; Caffeic Acids; Candida; Enoxacin; Female; Fluconazole; Intestines; Mice; Mice, Inbred BALB C; Naphthoquinones; NF-kappa B; Phenylethyl Alcohol

2007
Antifungal activity of naphthoquinoidal compounds in vitro against fluconazole-resistant strains of different Candida species: a special emphasis on mechanisms of action on Candida tropicalis.
    PloS one, 2014, Volume: 9, Issue:5

    Topics: Animals; Antifungal Agents; Candida; Candida tropicalis; Cell Line; Cell Survival; DNA Damage; DNA, Fungal; DNA, Ribosomal Spacer; Drug Resistance, Fungal; Fibroblasts; Fluconazole; Membrane Potential, Mitochondrial; Microbial Sensitivity Tests; Models, Chemical; Molecular Sequence Data; Molecular Structure; Naphthoquinones; Phosphatidylserines; Reactive Oxygen Species; RNA, Ribosomal, 5.8S; Sequence Analysis, DNA

2014
Action mechanism of naphthofuranquinones against fluconazole-resistant Candida tropicalis strains evidenced by proteomic analysis: The role of increased endogenous ROS.
    Microbial pathogenesis, 2018, Volume: 117

    Topics: Antifungal Agents; Candida tropicalis; Candidemia; Cell Cycle; DNA Damage; DNA, Fungal; Drug Resistance, Fungal; Energy Metabolism; Fluconazole; Glycolysis; Membrane Potential, Mitochondrial; Microbial Sensitivity Tests; Mitochondria; Naphthoquinones; Proteomics; Reactive Oxygen Species; Stress, Psychological

2018
β-Lapachone enhances the antifungal activity of fluconazole against a Pdr5p-mediated resistant Saccharomyces cerevisiae strain.
    Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2020, Volume: 51, Issue:3

    Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Drug Resistance, Multiple, Fungal; Drug Synergism; Fluconazole; Humans; Membrane Potential, Mitochondrial; Microbial Sensitivity Tests; Naphthoquinones; Reactive Oxygen Species; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins

2020